首页> 外文期刊>Journal of vascular surgery >Long-term results of Talent endografts for endovascular abdominal aortic aneurysm repair.
【24h】

Long-term results of Talent endografts for endovascular abdominal aortic aneurysm repair.

机译:Talent移植物用于血管内腹主动脉瘤修复的长期结果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Since the introduction of endovascular aneurysm repair (EVAR), long-term follow-up studies reporting single-device results are scarce. In this study, we focus on EVAR repair with the Talent stent graft (Medtronic, Santa Rosa, Calif). METHODS: Between July 2000 and December 2007, 365 patients underwent elective EVAR with a Talent device. Patient data were gathered prospectively and evaluated retrospectively. By American Society of Anesthesiologists category, 74% were categories III and IV. Postoperative computed tomography (CT) scanning was performed before discharge, at 3, 12 months, and yearly thereafter. Data are presented according to reporting standards for EVAR. RESULTS: The mean proximal aortic neck diameter was 27 mm (range, 16-36 mm), with a neck length <15 mm in 31% (data available for 193 patients). Deployment of endografts was successful in 361 of 365 patients (99%). Initially, conversion to laparotomy was necessary in four patients. Primary technical success determined by results from computed tomography (CT) scans before discharge was achieved in 333 patients (91%). Proximal type I endoleaks were present in 28 patients (8%) during follow-up, and 14 of these patients needed additional treatment for type I endoleak. The 30-day mortality for the whole Talent group was 1.1% (4 of 365). Follow-up to 84 months is reported for 24 patients. During follow-up, 122 (33%) patients died; in nine, death was abdominal aortic aneurysm (AAA)-related (including 30-day mortality). Kaplan-Meier estimates revealed primary clinical success rates of 98% at 1 year, 93% at 2 years, 88% at 3 years, 79% at 4 years, 64% at 5 years, 51% at 6 years, and 48% at 7 years. Secondary interventions were performed in 73 of 365 patients (20%). Ten conversions for failed endografts were performed. Life-table yearly risk for AAA-related reintervention was 6%, yearly risk for conversion to open repair was 1.1%, yearly risk for total mortality was 8.9%, and yearly risk for AAA-related mortality was 0.8%. CONCLUSION: Initially, technical success of endovascular aneurysm repair (EVAR) using the Talent endograft is high, with acceptable yearly risk for AAA-related mortality and conversion. However, a substantial amount of mainly endovascular reinterventions is necessary during long-term follow-up to achieve these results.
机译:背景:自从引入血管内动脉瘤修复术(EVAR)以来,缺乏长期随访研究报告了单装置结果。在这项研究中,我们专注于用Talent支架移植物(Medtronic,Santa Rosa,Calif)进行EVAR修复。方法:在2000年7月至2007年12月之间,对365例患者进行了采用Talent装置的择期EVAR。前瞻性收集患者数据并进行回顾性评估。按美国麻醉医师协会分类,74%属于III和IV类。出院前,3个月,12个月及其后每年进行术后计算机断层扫描(CT)扫描。数据根据EVAR的报告标准提供。结果:主动脉近端颈平均直径为27 mm(范围16-36 mm),颈长<15 mm占31%(数据可用于193例患者)。 365名患者中的361名(99%)成功部署了内移植物。最初,有四名患者必须转换为剖腹手术。主要的技术成功是由333例患者(91%)出院前通过计算机断层扫描(CT)扫描的结果确定的。随访期间28例患者(8%)存在I型近端内渗,其中14例患者需要I型内渗的进一步治疗。整个才能组的30天死亡率为1.1%(365个中的4个)。据报道,对24名患者进行了84个月的随访。在随访期间,有122名患者(33%)死亡。在9例中,死亡与腹主动脉瘤(AAA)相关(包括30天死亡率)。 Kaplan-Meier估计显示一级临床成功率在1年时为98%,在2年时为93%,在3年时为88%,在4年时为79%,在5年时为64%,在6年时为51%,在4年时为48% 7年。在365位患者中有73位(20%)进行了二次干预。对失败的内移植进行了十次转换。生命表中与AAA相关的再干预的年风险为6%,转换为开放式修复的年风险为1.1%,每年的总死亡风险为8.9%,而与AAA相关的死亡年风险为0.8%。结论:最初,使用Talent内移植物进行血管内动脉瘤修复(EVAR)的技术成功率很高,每年可接受的AAA相关死亡率和转化风险。但是,在长期随访期间,需要大量的主要是血管内再干预才能获得这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号